Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34+ cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF)

British Journal of Haematology

Volumn 100, Issue 1, 1998, Pages 207-218

  Catani, Lucia ^a,b   Gugliotta, Luigi ^a   Campanini, Elena ^a   Mangianti, Serena ^a   Gibellini, Davide ^a   Baravelli, Stefano ^a   Vianelli, Nicola ^a   Lemoli, Roberto Massimo ^a   Tura, Sante ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

CD34+ cells; CFU MK; IL 3; Mpl receptor expression; PEG rHuMGDF

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR;

ARTICLE; CELL PROLIFERATION; COLONY FORMING UNIT; DOSE RESPONSE; FLOW CYTOMETRY; GROWTH REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ANTIGENS, CD34; COLONY-FORMING UNITS ASSAY; DOSE-RESPONSE RELATIONSHIP, DRUG; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-3; MEGAKARYOCYTES; NEOPLASM PROTEINS; PHENOTYPE; POLYETHYLENE GLYCOLS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CYTOKINE; RECEPTORS, THROMBOPOIETIN; RECOMBINANT PROTEINS; THROMBOPOIETIN;

EID: 0031961895     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00511.x     Document Type: Article

References (58)

1. + cells in a serum-free system. British Journal of Haematology, 93, 13-17.
2. Banu, N., Wang, J.F., Deng, B., Groopman, J.E. & Avraham, H. (1995) Modulation of megakaryocytopoiesis by thrombopoietin: the c-mpl ligand. Blood, 86, 1331-1338.
3. Bartley, T.D., Bogenberger, J., Hunt, P., Li, Y.S., Lu, H.S., Martin, F., Chang, M.S., Samal, B., Nichol, J.L., Swift, S., Jonson, M.J., Hsu, R.Y., Parker, V.P., Suggs, S., Skrine, J.D., Merewether, L.A., Clogston, C., Hsu, E., Hokom, M.M., Hornkohl, A., Choi, E., Pangelinan, M., Sun, Y., Mar, V., McNinch, J., Simonet, L., Jacobsen, F., Xie, C., Shutter, J., Chute, H., Basu, R., Selander, L., Trollinger, D., Sieu, L., Padilla, D., Trail, G., Elliott, G., Izumi, R., Covey, T., Crouse, J., Garcia, A., Xu, W., Del Castillo, J., Biron, J., Cole, S., Hu, M.C.T., Pacifici, R., Pouting, I., Saris, C., Wen, D., Yung, Y.P., Lin, H. & Bosselman, R.A. (1994) Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell, 77, 1117-1124.
4. Basser, R.L., Rasko, J.E.J., Clarke, K., Cebon, J., Green, M.D., Hussein, S., Alt, C., Menchaca, D., Tomita, D., Marty, J., Fox, R.M. & Begley, C.G. (1996) Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHUMGDF) in patients with advanced cancer. Lancet, 348, 1279-1281.
5. Bretti, S., Kamthan, A. & Hicks, F. (1992) Phase I study of sequential IL-3 and GM-CSF by continuous intravenous infusion. Proceedings of the American Society of Clinical Oncology, 11, 537-542.
6. Carella, A.M., Pollicardo, N., Pungolino, E., Raffo, M.R., Podesta, M., Ferrero, R., Pierluigi, D., Nati, S., Naibo, K., Congiu, A., Spriano, M., Vimercati, R., Figari, O., Rosso, C., Saglio, G., Sessarego, M., Lercari, G., Valbonesi, M., Carlier, P., Vitale, V., Corvo, P. & Parodi, M. (1993) Mobilization of cytogenetically normal blood progenitors cells by intensive conventional chemotherapy for chronic myeloid and acute lymphoblastic leukemia. Leukemia and Lymphoma, 9, 477-502.
7. Debili, N., Wendling, F., Cosman, D., Titeux, M., Florindo, C., Dusanter-Fourt, I., Schooley, K., Methia, N., Charon, M., Nador, R., Bettaieb, A. & Vainchenker, W, (1995) The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood, 85, 391-401.
8. + cells measured under conditions that prevent P-selectin mediated binding of platelets. Blood, 86, 3771-3776.
9. De Sauvage, F.J., Hass, P.E., Spencer, S.D., Malloy, B.E., Gurney, A.L., Spencer, S.A., Darbonne, W.C., Henzel, W.J., Wong, S.C., Kuong, W-J., Oles, K.J., Hultgreen, B., Solberg, L.A., Goeddel, D.V. & Eaton, D.L. (1994) Stimulation of megakaryocytopoiesis by the c-mpl ligand. Nature, 369, 533-538.
10. D'Hondt, V., Weynants, P. & Humblet, Y. (1993) Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung cancer before and following chemotherapy. Journal of Clinical Oncology, 11, 2063-2071.
11. Donay, L., Laporte, J.P., Mary, J.Y., Lopez, M., Lemonnier, M.P., Stachowiol, J., Benitez, O., Deloux, J., Najman, A. & Salmon, C. (1987) Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA-Z 7557). Bone Marrow Transplantation. 2, 33-39.
12. Drexler, H.G. & Quentmeier, H. (1996) Thrombopoietin: expression of its receptor MpI and proliferative effects on leukemic cells. Leukemia, 10, 1405-1421.
13. Dyson, P.G., Jackson, K.A., McClure, B.J., Rawling, T.P. & To, L.B. (1996) Increased levels of megakaryocyte progenitors in peripheral blood mobilised by chemotherapy and/or hemopoietic growth factor protocols. Bone Marrow Transplantation, 18, 705-712.
14. Eaton, D.L. & De Sauvage, F.J. (1997) Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis. Experimental Hematology, 25, 1-7.
15. Fanucchi, M., Glaspy, J., Crawford, J., Garst, J., Figlin, R., Sheridan, W., Menchaca, D., Tomita, D., Ozer, H. & Harker, L. (1997) Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. New England Journal of Medicine, 336, 404-409.
16. First, L.R., Smith, B.R., Lipton, J., Nathan, D.G., Parkman, R. & Rappaport, J.M. (1985) Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndrome. Blood, 65, 368-374.
17. Ganser, A., Seipelt, G., Lindemann, A., Ottman, O.G., Falk, S., Eder, M., Herrman, F., Becher, R., Koffken, K., Buchner, T., Klausman, M., Frisch, J., Schulz, G., Mertlsmann, R. & Hoelzer, D. (1990) Effects of human recombinant interleukin-3 in patients with myelodysplastic syndromes. Blood, 76, 455-462.
18. Geissler, K., Valent, P. & Bettelheim, P. (1992) In vivo synergism of recombinant human interleukin-3 and recombinant human interleukin-6 on thrombopoiesis in primates. Blood, 79, 1155-1160.
19. Gewirtz, A.M. (1986) Human megakaryocytopoiesis. Seminars in Hematology, 23, 27-32.
20. Gianni, A.M., Siena, S., Bregni, M., Tarella, C., Stern, A.C., Pileri, A. & Bonadonna, G. (1989) Granulocyte-macrophage colony stimulating factor to harvest circulating haemopoietic stem cells for autotransplantations. Lancet, ii, 580-583.
21. Gugliotta, L., Bagnara, G.P., Catani, L., Gaggioli, L., Guarini, A., Zauli, G., Mattioli Belmonte, M., Lauria, F., Macchi, S. & Tura, S. (1989) In vivo and in vitro inhibitory effect of alpha-interferon on megakaryocyte colony growth in essential thrombocythaemia. British Journal of Haematology, 71, 177-181.
22. Henon, P.R. & Becker, M. (1993) Cytokine enhancement of peripheral blood stem cells. Stem Cells, 11, 65-68.
23. Hoffman, R. (1989) Regulation of megakaryocytopoiesis. Blood, 74, 1196-1212.
24. Hoffman, R. (1993) Interleukin-3: a potentially useful agent for treating chemotherapy-related thrombocytopenia. Journal of Clinical Oncology, 11, 2057-2060.
25. Jakubowski, A., Raptis, G. & Gilewski, T. (1992) A phase III trial of Pixy 321 (PIXY) in patients with metastatic breast cancer receiving doxorubicin and thiotepa. (Abstract). Blood, 80, 88a.
26. Kaushansky, K. (1995) Thrombopoietin: the primary regulator of platelet production. Blood, 86, 419-431.
27. Kaushansky, K., Broudy, V.C., Lyn, N., Jorgensen, M.J., McCarthy, J., Fox, N., Zucker-Dranklin, D. & Lofton-Day, C. (1995) Thrombopoietin, the MPL ligand. is essential for full megakaryocyte development. Proceedings of the National Academy of Sciences of the United States of America, 92, 3234-3238.
28. Kaushansky, K., Lok, S., Holly, R.D., Broudy, V.C., Lin, N., Bailey, M.C., Forstrom, J.W., Buddle, M.M., Ort, P.J., Hagen, F.S., Roth, G.J., Papayannopoulou, T. & Foster, D.C. (1994) Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature, 369, 568-571.
29. + cells to remove circulating tumor cells. Blood, 87, 1625-1634.
30. Lok, S., Kaushansky, K., Holly, R.D., Kuijper, J.L., Lofton-Day, C.E., Oort, P.J., Grant, F.J., Helpel, M.D., Burkhead, S.K., Kramer, J.M., Bell, L.A., Sprecher, C.A., Blumberg, H., Johnson, R., Prunkard, D., Ching, A.F.T., Mathewes, S.L., Balley, M.C., Forstrom, J.W., Buddle, M.M., Osborn, S.G., Evans, S.J., Sheppard, P.O., Presnell, S.R., O'Hara, P.J., Hagen, F.S., Roth, G.J. & Foster, D.C. (1994) Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature, 369, 565-568.
31. Lowry, P.A. & Tabbara, I.A. (1992) Peripheral blood hematopoietic stem cell transplantation: current concepts. Experimental Hematology, 20, 937-939.
32. Mazur, E.M. (1987) Human megakaryocytopoiesis and platelet production: a review. Experimental Hematology, 15, 340-350.
33. Molineaux, G., Hartley, C., McElroy, P., McCrea, C. & McNiece, I.K. (1996) Megakaryocyte growth and development factor accelerates platelet recovery in peripheral blood progenitor cell transplant recipients. Blood, 88, 366-376.
34. Nagler, A., Eldor, A., Naparstek, E., Mumcuoglu, M., Slavin, S. & Deutsch, V.R. (1996) Ex vivo expansion of megakaryocyte precursors by preincubation of marrow allografts with interleukin-3 and granulocyte-macrophage colony stimulating factor in vitro. Experimental Hematology, 23, 1268-1274.
35. Nichol, J., Hornkohl, A., Selesi, D., Wyres, M. & Hunt, P. (1995) Tpo levels in plasma of patients with thrombocytopenia or thrombocytosis. 37th Annual Meeting of the American Society of Hematology, Seattle, 1995 (Abstract no. 1474).
36. Patchen, M., MacVittie, T., Williams, J., Schwartz, G. & Souza, L. (1991) Administration of interleukin-6 stimulates multi-lineage hematopoiesis and accelerates recovery from radíation-induced hematopoietic depression. Blood, 77, 472-480.
37. Postmus, P.E., Gietma, J.A. & Damsa, O. (1992) Effects of recombinant interleukin-3 in patients with relapsed small-cell lung cancer treated with chemotherapy: a dose finding study. Journal of Clinical Oncology, 10, 1131-1140.
38. Richards, E.M., Jestice, H.K., Mahendra, P., Scott, M.A., Marcus, R.E. & Baglin, T.P. (1996) Measurement of reticulated platelets following peripheral blood progenitor cell and bone marrow transplantation: implications for marrow reconstitution and the use of thrombopoietin. Bone Marrow Transplantation, 17, 1029-1033.
39. Russell, N.H., Hunter, A., Rogers, S., Hanley, J. & Anderson, D. (1993) Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. (Letter). Lancet, 341, 1482.
40. Sale, G.E. & Buckner, C.D. (1988) Pathology of bone marrow transplant recipients. Hematology/Oncology Clinics of North America, 2, 735-743.
41. Schneider, J.G., Crown, J.P., Wasserheit, C., Knitz, A., Wong, G., Reich, L., Norton, L. & Moore, M.A.S. (1994) Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients. Bone Marrow Transplantation, 14, 877-882.
42. Sheridan, W.P., Begley, C.G., Juttner, C.A., Szer, J., Bikto, L., Maher, D., McGrath, K.M., Morstyn, G. & Fox, R.M. (1992) Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet, 339, 640-644.
43. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood, 86, 390-396.
44. + hematopoietic stem cells in the peripheral blood after high-dose cyclophosphamide treated patients: enhancement by intravenous recombinant granulocyte-macrophage colony stimulating factor. Blood, 74, 1905-1909.
45. Siena, S., Bregni, M., Bonsi, L., Sklenar, I., Bagnara, G.P., Bonadonna, G. & Gianni, M. (1993) Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high dose cyclophosphamide and hematopoietic growth factors. Experimental Hematology, 21, 1583-1590.
46. Soury, M., Vigon, I., Penciolelli, J.F., Heard, J-M., Tambourin, P. & Wendling, F. (1990) A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell, 63, 1137-1147.
47. Takatsuki, F., Okano, A. & Suzuki, C. (1990) Interleukin 6 perfusion stimulates reconstitution of the immune and hematopoietic systems after 5-fluorouracil treatment. Cancer Research, 50, 2885-2892.
48. Tewari, A. & Buhles, W., Jr (1990) Effects of interleukin-1 on platelet counts. Lancet, 336, 712-714.
49. + peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony stimulating factor. Blood, 84, 2795-2801.
50. + cells. Blood, 84, 2930-2939.
51. To, L.B., Shepperd, K.M., Haylock, D.N., Dyson, P.O., Charles, P., Thorp, D.L., Dale, B.M., Dart, G.W., Roberts, M.M., Sage, R.E. & Juttner, C.A. (1990) Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Experimental Hematology, 18, 442-446.
52. Ulich, T.R., Del Castillo, J., Senaldi, G., Kinstler, O., Songmei, Y., Kaufman, S., Tarpley, J., Choi, E., Kirley, T., Hunt, P. & Sheridan, W. (1996) Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice. Blood, 87, 5006-5015.
53. Vadhan-Raj, S., Papadopoulos, N. & Burgess, A. (1992) Pixy 321 (GM-CSF/IL-3 fusion protein) reduces chemotherapy induced multi-lineage myelosuppression in patients with sarcoma. Blood, 80, 249a.
54. Vose, J.M., Anderson, R.J., Kessinger, A., Bierman, P.J., Coccia, P., Reed, E.C., Gordon, B. & Armitage, J.O. (1993) High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. Journal of Clinical Oncology, 11, 1846-1851.
55. Weber, J., Yang, J.C. & Topalian, S.L. (1993) Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. Journal of Clinical Oncology, 11, 499-606.
56. Wendling, F., Maraskowsky, E., Debili, N., Florindo, C., Teepe, M., Titeux, M., Methia, N., Breton-Gorius, J., Cosman, D. & Vainchenker, W. (1994) c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature, 369, 571-574.
57. Zauli, G., Catani, L., Gugliotta, L., Gaggioli, L., Vitale, L., Mattioli Belmonte, M., Aglietta, M. & Bagnara, G.P. (1991) Essential thrombocythaemia: impaired regulation of megakaryocyte progenitors. International Journal of Cell Cloning, 9, 43-56.
58. Zauli, G. & Catani, L. (1995) Human megakaryocyte biology and pathophysiology. Critical Reviews in Oncology/Hematology, 21, 135-157.